Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs MEDVidi

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and MEDVidi head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 489 · Grade C

MEDVidi

Visit MEDVidi Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 51 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make MEDVidi a bad call — it's best for readers seeking appointment-based weight care who can confirm local prescribing access and pharmacy costs. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
40
Supply Reliability
95
69
Transparency
90
27
Access Breadth
93
36
Clinical Oversight
92
77
Track Record
88
68
CoreAge RxBrief Score 94 · 51MEDVidi

Price, coverage & the tracker

CoreAge RxMEDVidi
Brief Score94/100 (A)51/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

GLP-1 treatment considered when appropriate. Medication price requires confirmation.

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

GLP-1 treatment considered when appropriate. Medication price requires confirmation.

CoverageUS only; restrictions by state, confirmed at intakeConfirm weight-service availability and any in-person requirement for your state.
Brand-name accessNot confirmedLists Wegovy and Zepbound among weight-care options, subject to clinical assessment.
Oral / sublingualInjection onlyUnconfirmed
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

MEDVidi: Add the pharmacy estimate to the appointment cost.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.